GSK takes stake in biotech spin-out
October 5, 2010Research and Development, Sales and Marketing Convergence, GlaxoSmithKline, funding
GlaxoSmithKline has taken a stake in a newly-launched biotech company in return for handing it two clinical compounds. The pharma …
Elan debuts manufacturing services business
October 5, 2010Manufacturing and Production Elan
Irish pharmaceutical company Elan marked its official entry into the solid dose contract manufacturing sector today at the ongoing CPhI …
Recipharm buys Abbott plant to enter Spanish market
October 5, 2010Manufacturing and Production Abbott, Recipharm, Solvay
Swedish contract development and manufacturing services company Recipharm has agreed to buy a facility in Parets del Valles, Spain, from …
Digital Pharma: Pfizer socialises pain campaign
October 5, 2010Medical Communications Digital Pharma blog, Facebook, Flickr, Pfizer, Twitter, social media
Pfizer is campaigning for better care for people suffering from chronic pain and has turned to social media to galvanise …
Svend Andersen to lead Hospira in Europe
October 5, 2010Manufacturing and Production, Research and Development, Sales and Marketing Hospira, appointment, manufacturing and production, research and development, sales and marketing
US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …
Talking R&D: Evolving technical standards
October 5, 2010Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions
The European Union (EU) Module 1 specification works in parallel with the ICH eCTD Specification. It was first introduced in …
Sanofi makes hostile offer for Genzyme
October 4, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis’ courtship dance around Genzyme has turned more aggressive with an offer – made over the heads of Genzyme’s board …
Managing the Franchise
October 4, 2010Sales and Marketing branding, marketing, product portfolio
Commercial managers who are responsible for a number of brands face a constant dilemma in choosing where across the franchise …
Mitsui boosts contract manufacturing business
October 4, 2010Manufacturing and Production API, Arch Pharmalabs, India, Mitsui
Mitsui & Co has taken a 5% stake in Indian active pharmaceutical ingredients manufacturer Arch Pharmalabs in a $13 million …
Further expansion for Doctors.net.uk pharma team
October 4, 2010Sales and Marketing Doctors.net.uk, GPs, communications, doctors, pharma marketing
New hires to support and drive rapid growth
GSK drops herpes vaccine
October 4, 2010Research and Development, Sales and Marketing GlaxoSmithKline, Simplirix, herpes, sexual health
Poor phase III results have forced GlaxoSmithKline to halt development of its Simplirix vaccine for women with genital herpes. The …
David Gallagher to head up IPHA
October 4, 2010Sales and Marketing IPHA, appointment, sales and marketing
Pfizer Healthcare Ireland’s managing director David Gallagher has been elected president of the Irish Pharmaceutical Healthcare Association (IPHA). David has …
Talking R&D: US regulatory guidelines
October 4, 2010Manufacturing and Production, Research and Development Talking R&D, eCTD submissions
Recent speculation surrounding current diabetes drugs and their long term effect on cardiovascular health has heads spinning in the pharmaceutical …
Zydus Nycomed’s API plant to start production soon
October 4, 2010Manufacturing and Production API, India, Nycomed, Zydus Cadila
Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …
AZ-BMS diabetes drug impresses in phase III trials
October 1, 2010Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes
AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …
FDA unveils new trial data rules
October 1, 2010Research and Development FDA, clinical trials, pharmacovigilance
The FDA has clarified its rules on what safety information must be reported during clinical trials of investigational drugs and …
BMS poaches AZ’s head of global medical affairs
October 1, 2010Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing
Bristol-Myers Squibb has appointed Dr Rick Lones as executive medical director in the UK. He joins BMS from AstraZeneca, where …
New digital agency Intensity launched
October 1, 2010Medical Communications Creston, Intensity, OnMedica, Pan, Red Door
Medical communications group Creston has launched a new digital specialist agency called Intensity Digital. The start-up agency aims to serve …
J&J chief admits mistakes at Congressional hearing
October 1, 2010Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …
Sanofi signs $2.2bn CRO deal
October 1, 2010Research and Development CRO, Covance, Sanofi-Aventis
Sanofi-Aventis has signed a major deal to contract out a wide range of drug development and laboratory services as part …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
